ProKidney Corp.(PROK)
A cell therapy company developing a treatment for kidney disease.
1 Insight
Investment Insights
AI-generated insights about ProKidney Corp. from various financial sources
Wednesday, July 9, 2025
Very Bearish
Presented as a high-conviction short idea due to extreme skepticism about the company's scientific approach, lack of transparency, and a high borrow fee of 126%.
Wednesday, July 9, 2025
Very Bearish
Presented as a high-conviction short idea due to extreme skepticism about the company's scientific approach, lack of transparency, and a high borrow fee of 126%.